Cancer of the nasopharynx, also known as nasopharyngeal carcinoma (NPC), is a malignant tumor that develops in the nasopharynx region, which is located at the upper part of the throat, behind the nose. The nasopharynx is the air passage connecting the back of the nose to the upper part of the throat, just above the soft palate.
Nasopharyngeal carcinoma is a rare type of cancer that arises from the epithelial cells lining the nasopharynx. It is more common in certain areas of the world, particularly in Southeast Asia, North Africa, and the Arctic. The exact cause of this cancer is still unknown, but it has been strongly associated with the Epstein-Barr virus (EBV), a common virus that causes infectious mononucleosis.
The symptoms of cancer of the nasopharynx can vary depending on the stage of the disease but may include a persistent nasal congestion, snoring, recurrent nosebleeds, a lump in the neck, hearing loss, headaches, and facial pain. Diagnosis is typically made through imaging tests, such as MRI or CT scans, or by conducting a biopsy.
Treatment options for nasopharyngeal carcinoma include radiation therapy, chemotherapy, and sometimes surgery. The choice of treatment depends on various factors including the stage of the cancer, the size and location of the tumor, and the individual's overall health. Prognosis can vary depending on these factors, but early detection and timely treatment can significantly improve the chances of successful treatment and long-term survival. Regular follow-up visits and screenings are often recommended after treatment to monitor for any potential recurrence or complications.
